Biocon Limited — Important, 22-05-2025: General Updates

Biocon Biologics has secured a six-month extension for its insulin supply contract with the Malaysian Ministry of Health, continuing its decade-long partnership. The deal, fulfilled through its Johor facility and local partner Duopharma Marketing, strengthens Biocon’s foothold in Malaysia’s diabetes care market and supports its growth in affordable insulin supply across key international markets.